- Home
- NBH vs SOPH Comparison
NBH vs SOPH Comparison
Compare NBH & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBH
- SOPH
- Stock Information
- Founded
- NBH 2002
- SOPH 2011
- Country
- NBH United States
- SOPH Switzerland
- Employees
- NBH N/A
- SOPH N/A
- Industry
- NBH Finance/Investors Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NBH Finance
- SOPH Health Care
- Exchange
- NBH Nasdaq
- SOPH Nasdaq
- Market Cap
- NBH 328.2M
- SOPH 247.0M
- IPO Year
- NBH N/A
- SOPH 2021
- Fundamental
- Price
- NBH $11.03
- SOPH $3.40
- Analyst Decision
- NBH
- SOPH Strong Buy
- Analyst Count
- NBH 0
- SOPH 3
- Target Price
- NBH N/A
- SOPH $7.00
- AVG Volume (30 Days)
- NBH 85.9K
- SOPH 21.9K
- Earning Date
- NBH 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- NBH 4.34%
- SOPH N/A
- EPS Growth
- NBH N/A
- SOPH N/A
- EPS
- NBH 0.12
- SOPH N/A
- Revenue
- NBH N/A
- SOPH $64,938,000.00
- Revenue This Year
- NBH N/A
- SOPH $7.70
- Revenue Next Year
- NBH N/A
- SOPH $20.61
- P/E Ratio
- NBH $87.04
- SOPH N/A
- Revenue Growth
- NBH N/A
- SOPH 20.14
- 52 Week Low
- NBH $8.75
- SOPH $2.70
- 52 Week High
- NBH $11.01
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- NBH 45.73
- SOPH 44.10
- Support Level
- NBH $11.06
- SOPH $3.22
- Resistance Level
- NBH $11.17
- SOPH $3.66
- Average True Range (ATR)
- NBH 0.08
- SOPH 0.20
- MACD
- NBH -0.01
- SOPH 0.01
- Stochastic Oscillator
- NBH 33.86
- SOPH 58.60
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Intermediate Muni Fund is a closed-end management investment company that invests mainly in municipal securities. It aims to provide common stockholders a high level of current income exempt from Federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.